Install
Biotech
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
- 9 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
- Aerospace
- Agriculture
- Banking (Industry)
- Computing
- Consumer Goods
- Defense
- Energy & Utilities
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Real Estate (Commercial)
- Management & Consulting
- Manufacturing
- Technology
- Telecom
- Transportation & Logistics
- Automotive
- Construction
- Education & EdTech
- Hospitality & Travel
- Insurance (Industry)
- Mining & Materials
- Pharmaceuticals
Latest in Biotech
Redwire 10% holder plans sale of 929,435 shares
2+ week, 4+ day ago (229+ words) AE Red Holdings acquired the shares through a cashless exercise of 2 million warrants on June 11. The planned sale through Merrill Lynch is valued at $10.9M. Redwire 10% holder plans sale of 929,435 shares The shares were acquired through a cashless exercise of 2,000,000 warrants…...
Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development
26+ min ago (353+ words) New Delhi, The Ministry of Science's Technology Development Board has signed an agreement with Bengaluru-based Peptris Technologies Pvt Ltd for financial support of ₹86 crore to accelerate the development of next-generation therapies through Artificial Intelligence, it said on Monday. According to…...
The professionals getting ahead aren't climbing faster. They're changing direction
36+ min ago (374+ words) For decades, career progression followed a familiar script. Build expertise in one function. Climb steadily through the hierarchy. Become the recognised specialist. Repeat. Today, that model is changing. LinkedIn's 2026 global talent research reveals that while 52% of professionals are seeking new…...
Desentum secures €28M for faster allergy immunotherapy
2+ hour, 13+ min ago (429+ words) Finnish biotech Desentum has raised €28 million in an oversubscribed equity round to advance three allergy immunotherapy programs, with Phase 2 results for its lead birch pollen candidate expected before year-end. Why it matters: Desentum wants to shorten treatment that typically requires…...
US FDA approves Asahi Kasei's drug for persistent herpes infections
9+ min ago (39+ words) Published On Oct 12, 2026 at 07:45 AM IST Find this Comment Offensive? Join the community of 2M+ industry professionals. All about ETPharma industry right on your smartphone!...
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
17+ min ago (787+ words) FDA Fast Track designation is already granted, with additional ANB033 development planned in celiac disease, eosinophilic esophagitis and vitiligo. Among 32 efficacy-evaluable patients, Week 6 changes in villus height-to-crypt depth ratio, a measure of intestinal damage, were -0.17 versus -0.66 on placebo, a +0.49 difference (p…...
Avery Dennison exec sells 3,886 shares at $170
3+ week, 4+ day ago (310+ words) Avery Dennison (AVY) is a global materials science and digital identification solutions company focused on labeling, RFID, software and specialty materials. - [Form 4] Avery Dennison Corp Insider Trading Activity Avery Dennison exec sells 3,886 shares at $170 Avery Dennison’s SVP & CIO Nicholas Colisto…...
Is Oxford Biomedica (LSE:OXB) Gaining Attention As Its Vector Platform Broadens In October?
1+ hour, 1+ min ago (258+ words) It is one of the more specialised names on the London market, and its fortunes depend heavily on the progress of its clients' therapies through the clinic. The group built its name on LentiVector technology, and is now pushing its…...
Skydance Equity Warrants When Issued Exp 13th Oct 2036 SKYD'WI:NYSE
4+ hour, 10+ min ago (37+ words) Check out Skydance Equity Warrants When Issued Exp 13th Oct 2036's stock price (SKYD'WI) in real time CNBC Skydance Equity Warrants When Issued Exp 13th Oct 2036 SKYD'WI:NYSE There is no recent news for this security....
Emcure Pharma to Consolidate Operations by Merging Arms Zuventus, Emcutix
1+ hour, 54+ min ago (210+ words) The proposed scheme remains subject to the required statutory and regulatory approvals, including approval from the National Company Law Tribunal (NCLT), Mumbai Bench. All three entities operate in the pharmaceutical business. Emcure Pharmaceuticals is the holding company, while Zuventus Healthcare…...